Drug Eye Africa

Kenya sets 1 January 2027 deadline for GS1-compliant pharmaceutical serialization

The Pharmacy and Poisons Board (PPB) will require GS1-compliant unit-level serialization of health products from 1 January 2027.

The deadline was announced by Dr Bramuel Tongola, Technical Advisor to the PPB Chief Executive Officer, at the PharmaReg AfriSummit 2026 in Nairobi on 29 September 2026. The requirement will combine batch-level traceability with unit-level serialization under the national authentication and traceability system.

The system is anchored in Kenya’s Digital Health Act, 2023. PPB has already begun batch declarations for locally manufactured and imported products and, with the Digital Health Agency, developed a national product catalogue. Longer-term implementation will focus on broader serialization, advanced analytics, system integration and international interoperability.

Dr Tongola emphasized that effective traceability depends on accurate product and supply-chain event data. The phased approach aims to strengthen product authentication and traceability across the supply chain, improving visibility and supporting targeted recalls.

Sources

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top